CD8A and melanoma: Taken together, CD8+ T cells and NK cells were shown to play favorable roles in the survival of CRC and melanoma patients and the data obtained using the TICPE for several cohorts suggested that immune cell proportions can serve as an effective prognostic indicator for tumors.